Review Reports
by
- George Angelidis1,*,
- Stavroula Giannakou1 and
- Varvara Valotassiou1
- et al.
Reviewer 1: Anonymous Reviewer 2: Anonymous Reviewer 3: Anonymous
Round 1
Reviewer 1 Report
Comments and Suggestions for Authors- What is the role of (SSS), (SRS), and (SDS)?
- Abstract look very length. need not mention all the details?
- Any justification to myocardial infarction (MI) and cardiac death is linearly?
- Author please check the Line number 58-71.
- Inference of Table 1. Study exclusion criteria.?
- Need for Stress testing procedures?
- In 17 LV segments using a 5-point scoring system Why 5-point scoring system used?
- User mention about not used MYO software package, lease mention not used data from MYO software package?
- In section 2.6. Statistical Analysis add table graph to understand analysis easily.
- Use of table 3?
- In Discussion section need to improve provide analytic result rather than theorytical study.
Author Response
Please see the attachment.
Author Response File:
Author Response.doc
Reviewer 2 Report
Comments and Suggestions for Authors- Good literature review but doesn't adequately set up why this comparison (expert + automated vs angiography) is important. What is the clinical decision that would change based on these results?
- The temporal relationship between MPI and angiography is insufficiently described and potentially problematic. The authors states patients underwent angiography "prior to or after SPECT MPI (within a 3-month period)" but doesn't specify the distribution. I suggest providing explicit data on percentage with angiography before vs. after MPI, and median time interval.
- Logistic regression models were used to derive linear predictors - were these multivariable models? What covariates were included? How were the "combinations" of expert score + software created? Simple addition?
- All patients underwent both MPI and angiography, creating severe selection bias, since patients referred for angiography represent a high-risk subset. This fundamentally undermines the claimed "prognostic superiority" of MPI over angiography. Acknowledge this as a major limitation. The study compares prognostic accuracy in a select population already deemed to require angiography, not in the general population of patients with known/suspected CAD
- Event definitions are problematic. Hospitalizations (due to unstable angina, HF, or resuscitated CA) - these are vastly different endpoints with different relationships to ischemia. Moreoverm stroke is included as a "soft cardiac event" but cerebrovascular disease has different pathophysiology. Clarify event definitions and provide proper hierarchical event counts. Consider reporting time-to-first-event analyses
- Doğan et al. revealed strong correlation between semi-quantitative visual analysis of MPI findings and ICA data" - but the present study shows MPI is better than ICA for prognosis. The discussion doesn't adequately address this apparent contradiction
Author Response
Please see the attachment
Author Response File:
Author Response.doc
Reviewer 3 Report
Comments and Suggestions for Authors- Please clarify whether the visual MPI readers were fully blinded to angiographic findings and clinical follow-up information, as this directly affects validity.
- The rationale for including both expert scoring and automated measurements is sound, but the statistical approach for combining these inputs should be described in more detail.
- Consider expanding the limitations section to address the single-center sample, lack of attenuation correction, potential selection bias, and absence of external validation.
- The introduction could better highlight the current gaps in prognostic stratification and explain how this study fills those gaps.
Author Response
Please see the attachment
Author Response File:
Author Response.doc
Round 2
Reviewer 2 Report
Comments and Suggestions for AuthorsWell done.